mercatopartners.comMercato | Investing in Better

View All Discover by Status Active Private Public View All discover by role INVESTOR INVESTOR SUCCESS PERFORMANCE View All DISCOVER BY TYPE INSIGHTS NEWS STORIES Portfolio View All Discover by Status Active Private Public People View All discover by role INVESTOR INVESTOR SUCCESS PERFORMANCE Editorial View All DISCOVER BY TYPE INSIGHTS NEWS STORIES compass lp portal Prelude Savory careers contact privacy notice Disclaimers LAMBDA RAISES $320M SERIES C TO BUILD A GPU CLOUD FOR A.I. READ MORE Building better We invest in leaders that are changing how we live, learn and work—for the better. Investing in better views Build where you live. We’ll come to you. As investors, we believe your startup shouldn’t have to start on the coast. We’re committed to helping you build your business in the same place you’ve built your life. CONTACT US MERCATO LEADS LAMBDA LAB’S SERIES B Investing in better compute Learn More Core Beliefs We are a multi-practice investment firm that fundamentally believes in: The power of investing in underserved and underfunded geographies Giving more than we take Delivering value without compromising our values Bettering our world through entrepreneurship By the Numbers 1 GROWTH VENTURE FOOD/BEVERAGE GROWTH + - 4 Funds $1.0B Assets under management AUM $400M Active fund VENTURE + - 2 Funds $59M Assets under management $40M Active fund FOOD/BEVERAGE + - 2 Funds $329M Assets under management $100M Active fund Recent Investments 2 View All Vivante Health Team: Joe Kaiser, Mei Headley Vivante Health is a leading provider of digital gastrointestinal care that is reinventing the management of chronic gut conditions through data-driven technology, proven clinical protocols, and on-demand human support. Learn More B Series $31M Round Size Related Reading Why We Invested in Vivante Health Paytient Team: Joe Kaiser, Mei Headley Paytient is a healthcare finance technology company that partners with insurers to provide predictably affordable care for members. Paytient solves the first dollar of care” problem, and has already onboarded five of the nation ’ s largest 8 payers. Today, the company covers over a million lives on its platform. Learn More B Series $40M Round Size Related Reading Why We Invested in Paytient Lambda Team: Ryan Sanders Lambda provides computation to accelerate human progress. An artificial intelligence (AI) and deep learning infrastructure company, Lambda sells GPU cloud services and related software to the world ’ s largest enterprises, AI startups, and top-tier research universities. Learn More B Series $44M Round Size Related Reading Why We Invested in Lambda better informed Join our mailing list for the latest on building better . SUCCESS! YOU’VE BEEN SUBSCRIBED. Required Field Featured Editoral 3 View All 9.12.2023 Text Link ? Nausea, heartburn, indigestion, upset stomach, diarrhea ? This iconic, cheeky chorus line—a product of Publicis North America for Pepto-Bismol—was introduced by Procter and Gamble in 2002, and has since become permanently embedded into American pop culture. While most assuredly an attempt to grab attention, the jingle was also an attempt to break down American’s proverbial bathroom doors and normalize gastrointestinal (GI) issue relief. It was revolutionary at the time, and helped destigmatize internal dialogues around gut health. Unfortunately, it couldn’t solve for the psychological discomfort associated with seeking access to GI-related healthcare. Fast forward to today. The GI care options and access available to us far surpass those of the early 2000s thanks, in large part, to a tsunami of digital health adoption. Bolstered by the COVID-19 pandemic, the adoption of digital healthcare has experienced an unprecedented surge, revolutionizing the medical services landscape. Telemedicine, remote patient monitoring, and virtual consultations have swiftly emerged as cornerstones of patient care. This rapid integration of technology not only helped to address immediate health concerns during a global pandemic, but also set the stage for a more patient-centric and accessible healthcare future. The flexibility and discretion provided by this healthcare revolution was particularly impactful for GI digital health—a $78 billion market. Today, over 70 million Americans grapple with the challenges of managing GI issues, resulting in 8.3 million annual ER visits, and upwards of $136 billion in spend—a number greater than heart disease, trauma, or mental health. The dollars lost to GI issues, however, are only a fraction of the problem plaguing the patient population. Lost time, productivity, and quality of life are, undoubtedly, the more damaging side effects. Enter Vivante Health, our latest Traverse Fund IV investment, and a leading provider of digital GI care that is working to solve this problem. Led by their marquee virtual digestive health program, GIThrive, Vivante is reinventing the management of chronic gut conditions through data-driven technology, advanced science, and on-demand human support. Currently, the program is provided to patients free of charge as an employer benefit, and has been wildly successful. Members who work for Vivante customers—including, Walmart and US Foods—report consistent improvements in their quality of life, and satisfaction rates in excess of 90%. We have proven that our scalable technology platform paired with our comprehensive care team results in better health, lower costs, and a much better experience for the members we serve. – Bill Snyder, CEO Following our lead investment in their $31M Series B, Vivante is well positioned to be the category leader that solves for the digital consumer delivery blind spots that plague the entire health system. Their team of talented industry veterans, led by healthcare leader and CEO Bill Snyder, have set an ambitious vision for Vivante’s future, and are primed to be key contributors to the next era of U.S. healthcare. It is our firm belief that by reducing healthcare costs for employers, and increasing employee productivity and quality of life, Vivante is, undoubtedly, building better. This is some text inside of a div block. Why We Invested in Vivante Health News | Insight A Gut Instinct: Why Mercato Led Vivante Health’s $31M Series B Over 70 million Americans grapple with the challenges of managing GI issues, resulting in upwards of $136 billion in spend, lost time and productivity, and a lower quality of life. Vivante Health is addressing this problem by reinventing the management of chronic gut conditions, and solving for the digital consumer delivery blind spots that plague the entire health system. READ NOW 2.8.2023 Text Link For over 15 years we have had the privilege of partnering with visionary entrepreneurs and teams as they build transformational companies. Founded on the belief that capital champions change, we strive to invest diligently and equitably, deploying capital outside of venture-dense coastal cities and over-saturated technology hubs. By championing—what many consider to be— flyover” founders and funding their visionary ideas, we believe that venture and growth capital have the power to transform the technological and economic landscape of middle America. No place is a better example of this than Mercato’s home, Salt Lake City, Utah. In 2007, Greg Warnock and Alan Hall founded Mercato with the singular goal to bring local growth capital to the Wasatch valley. Rooted in a mutual passion for entrepreneurship, both founders understood that investing in local companies at the growth stage—and not just the venture stage—was a critical component of fueling the momentum of Utah’s start-up economy. By not having to rely on Bay Area or Big Apple VCs for later stage funding, Utah companies could partner with local investors that not only had deep community connections, but shared the common business values of service, stewardship, and sacrifice. Out of their first fund—a $52M private equity vehicle–Greg and Alan...